[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100374378":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":31,"responsibleParty":72,"collaborators":11,"id":74,"slug":75,"hasResults":76,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":80,"eligibilityCriteria":81,"healthyVolunteers":76,"sex":82,"minAge":83,"maxAge":11,"enrollmentInfo":84,"targetDuration":11,"studyType":87,"phases":88,"briefSummary":90,"conditions":91,"keywords":93,"overallStatus":59,"whyStopped":11,"lastUpdateSubmitDate":101,"lastUpdatePostDateStruct":102,"startDateStruct":105,"completionDateStruct":107,"leadSponsor":109,"locationsCount":110},{"fullName":5,"class":6},"Hospices Civils de Lyon","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"group using Cellvizio® optical biopsy","EXPERIMENTAL",null,[13],"Device: Cellvizio®",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":11},"DEVICE","Cellvizio®","use of the Cellvizio® optical biopsy",[9],[21],{"name":22,"affiliation":23,"role":24},"Gautier CHENE, MD","Gynaecology Department, Hôpital Femme Mère Enfant Hospices Civils de Lyon","PRINCIPAL_INVESTIGATOR",[26],{"name":22,"role":27,"phone":28,"phoneExt":29,"email":30},"CONTACT","(4) 72 35 58 70","+33","gautier.chene@chu-lyon.fr",[32,57],{"facility":33,"status":34,"city":35,"state":11,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Gynaecology Department, Hôpital Femme Mère Enfant Hospices Civisl de Lyon","NOT_YET_RECRUITING","Bron","69500","France","FR",{"type":40,"coordinates":41},"Point",[42,43],4.91303,45.73865,{"lat":43,"lon":42},[46,47,48,51,53,55],{"name":22,"role":27,"phone":28,"phoneExt":29,"email":30},{"name":22,"role":24,"phone":11,"phoneExt":11,"email":11},{"name":49,"role":50,"phone":11,"phoneExt":11,"email":11},"Gery LAMBLIN, MD","SUB_INVESTIGATOR",{"name":52,"role":50,"phone":11,"phoneExt":11,"email":11},"Philippe Chabert, MD",{"name":54,"role":50,"phone":11,"phoneExt":11,"email":11},"Karine Lebail-Carval, MD",{"name":56,"role":50,"phone":11,"phoneExt":11,"email":11},"Erdogan Nohuz, MD",{"facility":58,"status":59,"city":35,"state":11,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":60,"geoPoint":62,"contacts":63},"Service de Gynécologie, HFME, Hospices Civils de Lyon","RECRUITING",{"type":40,"coordinates":61},[42,43],{"lat":43,"lon":42},[64,65,66,68,70,71],{"name":22,"role":27,"phone":11,"phoneExt":11,"email":30},{"name":22,"role":24,"phone":11,"phoneExt":11,"email":11},{"name":67,"role":50,"phone":11,"phoneExt":11,"email":11},"Philippe CHABERT, MD",{"name":69,"role":50,"phone":11,"phoneExt":11,"email":11},"Géry LAMBLIN, MD",{"name":54,"role":50,"phone":11,"phoneExt":11,"email":11},{"name":56,"role":50,"phone":11,"phoneExt":11,"email":11},{"type":73,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100374378","optical-biopsy-in-gynecological-surgery-100374378",false,"NCT04154683","Optical Biopsy in Gynecological Surgery","Diagnostic Performance of Optical Biopsy by Cellvizio® in Gynecological Surgery","GYNECOPTIC","Inclusion Criteria:\n\n* Women aged 18 years or more\n* Informed and signed consent\n* Planned surgery under laparoscopy and included in the list below:\n\n  * unilateral or bilateral salpingectomy\n  * hysterectomy\n  * ovariectomy\n  * surgery of endometriosis\n  * surgery for cancer of the cervix, endometrium, ovaries\n\nExclusion Criteria:\n\n* Interview revealing disorder entailing unacceptable risk of postoperative complications: coagulation disorder, immune system disorder, evolutive disease, etc.\n* Pregnancy or desire of pregnancy during the study period, breastfeeding\n* Hypersensitivity to Fluorescein or any of its excipients\n* History of life-threatening reaction during angiography\n* Known allergic reactions and hypersensitivity\n* Severe asthma, heart and \u002F or lung disease, diabetes\n* Person on beta-blocker treatment\n* Inability to understand information provided\n* Not covered by a national health insurance scheme, prisoner or under administrative supervision","FEMALE","18 Years",{"count":85,"type":86},80,"ESTIMATED","INTERVENTIONAL",[89],"NA","Optical biopsy is a new technology that generates a real-time, cell-based, high-resolution view and analysis of tissues. Observation is instantaneous and non-invasive. This allows reliable and fast diagnosis which facilitates decision making as well as patient management.\n\nThe investigator have already conducted a feasibility study on the use of this new technology to evaluate ovarian and tubal pre-cancerous lesions in laparoscopy. In this new study, he wants to continue investigations, expand its use to other gynecological pathologies, and demonstrate the benefit of such a non-invasive technology in gynecology on the one hand in the diagnosis of lesions but also to appreciate the margins as accurately as possible surgical excision of tumors and \u002F or endometriosis lesions.\n\nThe investigator have set up a prospective monocentric descriptive study. The hypothesis is that optical biopsy by Cellvizio® allows to observe in real time microscopically tissues and to characterize them in the field of gynecological surgery",[92],"Gynecologic Surgical Procedures",[94,17,95,96,97,98,99,100],"salpingectomy","optical biopsy","unilateral or bilateral salpingectomy","ovariectomy","Endometriosis","surgery for cervical","ovarian cancer","2026-01-14",{"date":103,"type":104},"2026-01-15","ACTUAL",{"date":106,"type":104},"2020-06-29",{"date":108,"type":86},"2026-06-29",{"name":5,"class":6},2]